Who oversaw the Saltikva Phase 2 trial?

The Phase 2 principal investigators were Gerald Batist, MD and Petr Kavan, MD (Jewish General Hospital, Montreal). Salspera's CMO, Daniel Saltzman, MD, PhD, is the principal investigator on the IND. An independent Data Safety and Monitoring Committee oversaw safety; it is no longer active, and former member Christopher Moertel, MD later joined Salspera's Scientific Advisory Board.